
### [NCIT:C7402](http://purl.obolibrary.org/obo/NCIT_C7402)
**Label:** Hairy Cell Leukemia

**Subclasses:** [NCIT:C8030](http://purl.obolibrary.org/obo/NCIT_C8030) (Refractory Hairy Cell Leukemia), [NCIT:C8029](http://purl.obolibrary.org/obo/NCIT_C8029) (Progressive Hairy Cell Leukemia Initial Treatment), [NCIT:C7301](http://purl.obolibrary.org/obo/NCIT_C7301) (Splenic Manifestation of Hairy Cell Leukemia), 

**Class expressions from DL-Learner:**

- [NCIT:C36445](http://purl.obolibrary.org/obo/NCIT_C36445) (Clonal Immunoglobulin Light Chain Gene Rearrangement) 57.14%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27886](http://purl.obolibrary.org/obo/NCIT_C27886) (Type 1 Papillary Renal Cell Carcinoma))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27882](http://purl.obolibrary.org/obo/NCIT_C27882) (Bladder Low Grade Intraurothelial Neoplasia))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27876](http://purl.obolibrary.org/obo/NCIT_C27876) (Non-Invasive Bladder Papillary Urothelial Carcinoma, High Grade))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27854](http://purl.obolibrary.org/obo/NCIT_C27854) (Angiofollicular Lymphoid Hyperplasia, Plasma Cell Type))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27853](http://purl.obolibrary.org/obo/NCIT_C27853) (Angiofollicular Lymphoid Hyperplasia, Hyaline-Vascular Type))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27851](http://purl.obolibrary.org/obo/NCIT_C27851) (Human Papillomavirus Infection))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27850](http://purl.obolibrary.org/obo/NCIT_C27850) (Endometrial Endometrioid Adenocarcinoma with Spindled Epithelial Cells))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27849](http://purl.obolibrary.org/obo/NCIT_C27849) (Oxyphilic Endometrial Endometrioid Adenocarcinoma))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27846](http://purl.obolibrary.org/obo/NCIT_C27846) (Villoglandular Endometrial Endometrioid Adenocarcinoma))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27845](http://purl.obolibrary.org/obo/NCIT_C27845) (Endometrial Endometrioid Adenocarcinoma with an Undifferentiated Carcinomatous Component))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27844](http://purl.obolibrary.org/obo/NCIT_C27844) (Endometrial Endometrioid Adenocarcinoma with a Poorly Differentiated Carcinomatous Component))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27843](http://purl.obolibrary.org/obo/NCIT_C27843) (Endometrial Endometrioid Adenocarcinoma with Clear Cell Change))) 54.02%
- [NCIT:C36443](http://purl.obolibrary.org/obo/NCIT_C36443) (Clonal Immunoglobulin Gene Rearrangement) and (not ([NCIT:C27839](http://purl.obolibrary.org/obo/NCIT_C27839) (Endometrial Endometrioid Adenocarcinoma, Secretory Variant))) 54.02%


